Skip to Content
Merck
  • Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study.

Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study.

Pharmacotherapy (1993-05-01)
H Jick, L E Derby, L A García Rodríguez, S S Jick, A D Dean
ABSTRACT

We performed a population-based study of over 100,000 users of diclofenac, naproxen, or piroxicam to identify cases of important blood, skin, central nervous system, kidney, pancreas, or pulmonary disorders caused by these drugs. In three cases a causal relation seemed likely; one of hemolytic anemia attributed to diclofenac, one of neutropenia attributed to naproxen, and one of pancreatitis attributed to piroxicam. In 13 additional cases a causal connection seemed unlikely but could not be fully ruled out. We conclude that such illnesses are uncommonly caused by the three agents studied.

MATERIALS
Product Number
Brand
Product Description

Naproxen, European Pharmacopoeia (EP) Reference Standard
Supelco
Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Naproxen, meets USP testing specifications
Sigma-Aldrich
(S)-(+)-6-Methoxy-α-methyl-2-naphthaleneacetic acid, 98%
Supelco
Naproxen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Naproxen, VETRANAL®, analytical standard